JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
WhiteHorse Finance (WHF) Prices 2.35M Common Stock Offering by Selling Stockholders at $14/Share
-
WhiteHorse Finance, Inc. Announces Pricing of Public Offering by Selling Stockholders
-
Sorrento Therapeutics to Present at the JMP Securities Life Sciences Conference in New York (NY)
-
LiveXLive Media (LIVX) PT Lowered to $5 at JMP Securities
-
Zafgen to Present at the JMP Securities Life Sciences Conference
-
Zafgen to Present at the JMP Securities Life Sciences Conference
-
Heron Therapeutics to Present at 2019 JMP Securities Life Sciences Conference
-
Savara to Present at the JMP Securities Life Sciences Conference
-
Fiverr International (FVRR) IPO Opens 24% Higher
-
Novan to Participate in JMP Securities Life Sciences Conference
-
TELA Bio® to Participate in JMP Securities Life Sciences Conference
-
Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19
-
Arbutus to Participate at JMP Securities Life Sciences Conference
-
Homology Medicines to Present at JMP Securities Life Sciences Conference
-
Arbutus to Participate at JMP Securities Life Sciences Conference
-
Bellerophon to Present at the JMP Securities Life Sciences Conference
-
Intrexon's Subsidiary Precigen to Present at the JMP Securities Life Sciences Conference
-
Newron Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
-
CTI BioPharma to Present at the JMP Securities Life Sciences Conference on Thursday, Jun. 20
-
Syndax to Present at the JMP Securities Life Sciences Conference
-
BioLineRx to Present at the JMP Securities 2019 Life Sciences Conference
-
Achillion to Present at the JMP Securities Life Sciences Conference
-
Cambium Networks Corporation Announces Launch of Initial Public Offering
-
Cambium Networks Corporation Announces Launch of Initial Public Offering
-
Fiverr International Ltd. (FVRR) Prices 5.263M Share IPO at $21/Sh
-
JMP Securities Downgrades Savara (SVRA) to Market Perform
-
Fiverr International Ltd. Announces Pricing of Initial Public Offering
-
MediciNova to Present at the JMP Securities Life Sciences Conference
-
MediciNova to Present at the JMP Securities Life Sciences Conference
-
Sabra Health Care REIT, Inc. to Attend the Mizuho REIT/Real Estate Conference and Participate in the 2019 JMP Securities Boston Real Estate 1x1 Forum
-
Nuvectra® to Participate in Two Upcoming Investor Conferences
-
Cytokinetics to Present at the JMP Securities Life Sciences Conference
-
CrowdStrike (CRWD) IPO Opens 89% Higher
-
Biofrontera to Present at Two Upcoming Investor Conferences
-
Biofrontera to Present at Two Upcoming Investor Conferences
-
MannKind to Present at the JMP Securities Life Sciences Conference
-
MannKind to Present at the JMP Securities Life Sciences Conference
-
Minerva Neurosciences to Present at JMP Securities Life Sciences Conference
-
Minerva Neurosciences to Present at JMP Securities Life Sciences Conference
-
Syros to Present at JMP Securities Life Sciences Conference
-
Aimmune to Present at the JMP Securities Life Sciences Conference
-
Neos Therapeutics to Present at Two Upcoming June Conferences
-
Strongbridge Biopharma plc to Present at the 2019 JMP Securities Life Sciences Conference
-
CrowdStrike Holdings Inc. (CRWD) Prices 18M Class A Share IPO at $34/Sh
-
Azure Power Global Limited (AZRE) PT Lowered to $26 at JMP Securities
-
CrowdStrike Announces Pricing of Initial Public Offering
-
CrowdStrike Announces Pricing of Initial Public Offering
-
STRATA Skin Sciences to Present at Upcoming Investor Conferences
-
ChemoCentryx to Present at Two Upcoming Investor Conferences
-
ChemoCentryx to Present at Two Upcoming Investor Conferences

